The AGI debate has intensified in April 2026 as leading AI laboratories escalate capability claims while researchers dispute the definitions being used.
The formation of protein amyloid fibrils in the brain is a hallmark of various neurodegenerative diseases, including Alzheimer diseases and Parkinson diseases. Amyloid f ...